跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CU-102
首页
药物
CU-102
CU-102
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Adefovir dipivoxil anhydrous crystal, preparation method and medicine composition thereof
CN 101054393 B
申请人: SHANGHAI MODERN PHARMACEUTICAL CO LTD
优先权: 2006
CN
Medical pantoprazole sodium composition tablet for treating gastric ulcer
CN 104856994 A
申请人: MIAO YIWEN
优先权: 2015
CN
Ezetimibe composition capsule for treating cardio-cerebral vascular system diseases
CN 104983713 A
申请人: QINGDAO LANSHENGYANG PHARMACEUTICAL & BIOTECHNOLOGY CO LTD
优先权: 2015
CN
Ambroxol hydrochloride composition tablet as medicine for treating respiratory disease
CN 104940155 A
申请人: QINGDAO LANSHENGYANG MEDICINE BIOLOG SCIENCE & TECHNOLOGY CO LTD
优先权: 2015
CN
Medicine and spryceltm composition tablet for treating leukemia
CN 105012263 A
申请人: QINGDAO LANSHENGYANG MEDICAL BIOLOG TECHNOLOGY CO LTD
优先权: 2015
CN
Fasudil hydrochloride composition tablets capable of improving cerebral vasospasm
CN 105106155 A
申请人: QINGDAO HUAZHICAO MEDICAL TECHNOLOGY CO LTD
优先权: 2015
CN
Atorvastatin calcium composition tablet for treating hypercholesteremia
CN 105055357 A
申请人: QINGDAO HUAZHICAO PHARMACEUTICAL CO LTD
优先权: 2015
CN
药物
反馈